When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   Recent steps suggest that options for colorectal cancer screening are continuing to expand. Why did the FDA approve the new colon cancer blood test? On July 29, 2024, ...

3. A new type of bacteria was found in 50% of colon cancers ...

   www.aol.com/news/type-bacteria-found-50-colon...

   Colon cancer is the second-leading cause of cancer deaths in the United States and is expected to kill more than 53,000 people in the nation in 2024, according to the American Cancer Society.

4. A new way to screen for colon cancer may be on the horizon ...

   www.aol.com/news/way-screen-colon-cancer-may...

   Colon cancer screening is generally recommended starting at age 45, but less than 60% of people who are eligible are up to date. “In an ideal world, everyone goes to get a first colonoscopy at 45.

5. Colorectal cancer - Wikipedia

   en.wikipedia.org/wiki/Colorectal_cancer

   Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). [5] Signs and symptoms may include blood in the stool , a change in bowel movements , weight loss, abdominal pain and fatigue. [ 9 ]

6. Cancer treatment - Wikipedia

   en.wikipedia.org/wiki/Cancer_treatment

   Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]

7. FOLFOX - Wikipedia

   en.wikipedia.org/wiki/FOLFOX

   Adjuvant treatment in patients with stage III colon cancer is recommended [2] for 12 cycles, every two weeks. The recommended dose schedule is as follows: Day 1: Oxaliplatin 85 mg/m 2 intravenous (IV) infusion in 250-500 mL D5W and leucovorin 200 mg/m 2 IV infusion in D5W administered concurrently over 120 minutes in separate bags using a Y-line, followed by fluorouracil (5-FU) 400 mg/m 2 IV ...